Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine TherapyMAHFOUZ, Reda Z; JANKOWSKA, Ania; ENGELKE, Kory J et al.Clinical cancer research (Print). 2013, Vol 19, Num 4, pp 938-948, issn 1078-0432, 11 p.Article

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromesSEKERES, Mikkael A; TIU, Ramon V; TABARROKI, Ali et al.Blood. 2012, Vol 120, Num 25, pp 4945-4951, issn 0006-4971, 7 p.Article